CJC-1295 NO DAC – & IPAMORELIN (5MG/5MG) BLEND | RESEARCH PEPTIDE

Product Points : 50Points

$37.00

CJC No DAC with Ipamorelin is a synthetic peptide combination studied in laboratory research. Researchers examine how it supports growth hormone signaling through GHRH and ghrelin receptor pathways. Supplied as a lyophilized compound for controlled research use only. ⚠️

In stock

Add to Wishlist
Add to Wishlist
Secure Payment Methods

Description

CJC No DAC with Ipamorelin – Laboratory Use Only

CJC No DAC with Ipamorelin is a research compound supplied as a lyophilized powder for laboratory study. Researchers examine how these peptides interact with growth hormone signaling pathways. In addition, laboratories analyze receptor binding and signal response under controlled conditions. This product is intended strictly for research use only.

Understanding the Role of CJC No DAC

CJC No DAC is a synthetic growth hormone–releasing hormone (GHRH) analog. It acts on receptors in the pituitary gland. As a result, it helps stimulate natural growth hormone signaling. However, unlike long-acting versions, CJC No DAC has a shorter activity window.

Because of this shorter action time, researchers can observe pulse-like signaling patterns. Therefore, laboratories often use it to study timing and release dynamics in controlled models.

Understanding the Role of Ipamorelin

Ipamorelin is a synthetic growth hormone secretagogue. It works differently from CJC. Instead of acting on GHRH receptors, it binds to ghrelin (GHS-R1a) receptors. Consequently, it stimulates growth hormone release through a separate signaling pathway.

In contrast to broader secretagogues, Ipamorelin shows selective receptor activity in laboratory settings. Because of this selectivity, researchers use it to evaluate receptor-specific responses.

Why Researchers Study the Combination

CJC No DAC and Ipamorelin influence growth hormone signaling through different receptors. Therefore, researchers often study them together to observe combined pathway effects. First, CJC activates the GHRH receptor pathway. Then, Ipamorelin activates the ghrelin receptor pathway. As a result, scientists can compare dual-pathway signaling under structured conditions.

For comparison research involving other GHRH analogs, you may also review Tesamorelin.

⚗ Molecular Overview

  • Classification: Synthetic peptide combination
  • Format: Lyophilized powder
  • Intended Use: Laboratory research only

Before experimentation begins, laboratories confirm identity using analytical methods such as HPLC and mass spectrometry. This step supports research accuracy and documentation.

❄ Storage & Handling

Store dry material at −20°C or colder. After reconstitution, refrigerate between 2–8°C. Also avoid repeated freeze–thaw cycles. Finally, protect from direct light to help maintain stability.

Related Research Materials

You may also review
TESAMORELIN 10MG | RESEARCH PEPTIDE and
Bacteriostatic Water 20mL
for laboratory procedures.

External Scientific References

⚠ Research Use Disclaimer

This compound is intended strictly for laboratory and analytical research. It is not intended for diagnostic, therapeutic, or clinical use.

Reviews

There are no reviews yet

Be the first to review “CJC-1295 NO DAC – & IPAMORELIN (5MG/5MG) BLEND | RESEARCH PEPTIDE”
Review now to get coupon!

Your email address will not be published. Required fields are marked *